Intimation for retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director of the Company upon completion of his first term, with effect from close of business hours on June 22, 2026.

Bafna Pharmaceuticals Ltd announced the routine retirement of Mr. Navin Kumar, an Independent Director, upon the completion of his first term, effective June 22, 2026. As a result, he will also cease to be the Chairman of the Audit Committee and the Nomination & Remuneration Committee. The company has subsequently reconstituted these committees, stating that the composition of the Board and its committees remains compliant with applicable regulations.